"Muscle Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.
Descriptor ID |
D019042
|
MeSH Number(s) |
C04.588.839.500 C05.651.494
|
Concept/Terms |
Muscle Neoplasms- Muscle Neoplasms
- Neoplasms, Muscle
- Muscle Neoplasm
- Neoplasm, Muscle
Cancer of Muscle- Cancer of Muscle
- Muscle Cancers
- Muscle Cancer
- Cancer, Muscle
- Cancers, Muscle
- Cancer of the Muscle
|
Below are MeSH descriptors whose meaning is more general than "Muscle Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Muscle Neoplasms".
This graph shows the total number of publications written about "Muscle Neoplasms" by people in this website by year, and whether "Muscle Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 2 | 2 | 4 |
2019 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Muscle Neoplasms" by people in Profiles.
-
Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centre. BMC Musculoskelet Disord. 2021 Jan 05; 22(1):18.
-
Diagnostic value of spectral reconstructions in detecting incidental skeletal muscle metastases in CT staging examinations. Cancer Imaging. 2019 Jul 17; 19(1):50.
-
Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect. Eur Urol. 2019 10; 76(4):425-429.
-
Non-small cell lung cancer presenting as "psoas muscle syndrome". Monaldi Arch Chest Dis. 2019 Apr 05; 89(1).
-
PET in the Diagnostic Management of Soft Tissue Sarcomas of Musculoskeletal Origin. PET Clin. 2018 Oct; 13(4):609-621.
-
[ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology]. Prog Urol. 2018 Oct; 28(12):567-574.
-
Clodronate in the management of different musculoskeletal conditions. Minerva Med. 2018 Aug; 109(4):300-325.
-
Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. Urol Oncol. 2018 05; 36(5):239.e1-239.e7.
-
Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Cancer. 2017 Nov 15; 123(22):4346-4355.
-
PET-CT demonstration of extensive muscle metastases from breast cancer. Clin Nucl Med. 2006 May; 31(5):266-8.